Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E Ming

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Journal of Surgical Oncology|July 28, 2022
Association of type II diabetes mellitus with characteristics and outcomes for patients undergoing sentinel lymph node biopsy for cutaneous melanomaRichard J Straker, Gabriella N Tortorello, Cimarron E Sharon, et al.
Annals of Surgical Oncology|February 8, 2007
Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patientsGiorgos C Karakousis, Phyllis A Gimotty, Brian J Czerniecki, et al.
Journal of the American Academy of Dermatology|August 16, 2019
Use of new molecular tests for melanoma by pigmented-lesion expertsAmir Varedi, Laura J Gardner, Caroline C Kim, et al.
Journal of Cutaneous Pathology|July 23, 2004
Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologistsMichael Shapiro, Mary-Margaret Chren, Ross M Levy, et al.
Journal of the American Academy of Dermatology|May 25, 2025
Utility of sentinel lymph node biopsy for acral lentiginous melanoma in the contemporary era: A national cohort analysisMohammad S Farooq, Neha Shafique, Gracia M Vargas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanomaPhyllis A Gimotty, Patricia Van Belle, David E Elder, et al.
Cancer|October 24, 2006
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanomaLaura L Kruper, Francis R Spitz, Brian J Czerniecki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2011
Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanomaXiaowei Xu, Lianjun Chen, DuPont Guerry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2007
Identification of high-risk patients among those diagnosed with thin cutaneous melanomasPhyllis A Gimotty, David E Elder, Douglas L Fraker, et al.
Journal of the American Academy of Dermatology|July 17, 2017
Risk factors for positive or equivocal margins after wide local excision of 1345 cutaneous melanomasChristopher J Miller, Thuzar M Shin, Joseph F Sobanko, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Journal of Surgical Oncology|July 28, 2022
Association of type II diabetes mellitus with characteristics and outcomes for patients undergoing sentinel lymph node biopsy for cutaneous melanomaRichard J Straker, Gabriella N Tortorello, Cimarron E Sharon, et al.
Annals of Surgical Oncology|February 8, 2007
Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patientsGiorgos C Karakousis, Phyllis A Gimotty, Brian J Czerniecki, et al.
Journal of the American Academy of Dermatology|August 16, 2019
Use of new molecular tests for melanoma by pigmented-lesion expertsAmir Varedi, Laura J Gardner, Caroline C Kim, et al.
Journal of Cutaneous Pathology|July 23, 2004
Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologistsMichael Shapiro, Mary-Margaret Chren, Ross M Levy, et al.
Journal of the American Academy of Dermatology|May 25, 2025
Utility of sentinel lymph node biopsy for acral lentiginous melanoma in the contemporary era: A national cohort analysisMohammad S Farooq, Neha Shafique, Gracia M Vargas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanomaPhyllis A Gimotty, Patricia Van Belle, David E Elder, et al.
Cancer|October 24, 2006
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanomaLaura L Kruper, Francis R Spitz, Brian J Czerniecki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2011
Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanomaXiaowei Xu, Lianjun Chen, DuPont Guerry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2007
Identification of high-risk patients among those diagnosed with thin cutaneous melanomasPhyllis A Gimotty, David E Elder, Douglas L Fraker, et al.
Journal of the American Academy of Dermatology|July 17, 2017
Risk factors for positive or equivocal margins after wide local excision of 1345 cutaneous melanomasChristopher J Miller, Thuzar M Shin, Joseph F Sobanko, et al.
Pageof 8